Quest Diagnostics stock heads into the open after a 1.6% gain
Published on 09/14/2026 at 08:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Quest Diagnostics stock closed at USD 234.80 on the NYSE on September 11, 2026, gaining 1.6% for the session. That move left the shares roughly in line with the broader US equity benchmarks, which also advanced on September 11, 2026.
September 11, 2026 in numbers
Quest Diagnostics Inc. (ISIN US74834L1008, NYSE: DGX) ended the September 11, 2026 NYSE session at USD 234.80, up USD 3.66 or 1.59% from the prior close, according to NYSE data cited by MarketBeat. The stock traded within a daily range that kept the close inside its prevailing 52-week band, and turnover on September 11, 2026 was broadly consistent with recent days, indicating measured participation rather than a spike in activity.
On the same day, major US indices also advanced, with the S&P 500 closing higher as reported by MINKABU PRESS, underscoring a generally constructive market tone for large-cap US stocks on September 11, 2026. In that context, Quest Diagnostics stock tracked the health-care sector’s positive bias rather than showing an outsized, company-specific reaction.
Today’s outlook for Quest Diagnostics
Today, September 14, 2026, Quest Diagnostics enters the US session without a newly reported company-specific event before the opening bell in the past hours, leaving broader market drivers as the main potential influences on the stock. Upcoming earnings calendars for mid-September 2026 compiled by Yahoo Finance do not list Quest Diagnostics reporting results today, so the shares are likely to respond primarily to sector moves in US health care and to macroeconomic data scheduled for this week. With US indices having closed higher on September 11, 2026, the starting point into today’s session is a market that recently showed resilience, which can shape the short-term trading environment for Quest Diagnostics stock.
